MetLife Investment Management’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Buy |
+15,825
| New | +$189K | ﹤0.01% | 2231 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2864 |
|
|
2024
Q2 | – | Sell |
-12,254
| Closed | -$83.3K | – | 2889 |
|
|
2024
Q1 | $83.3K | Hold |
12,254
| – | – | ﹤0.01% | 2618 |
|
|
2023
Q4 | $83.2K | Hold |
12,254
| – | – | ﹤0.01% | 2681 |
|
|
2023
Q3 | $61.4K | Hold |
12,254
| – | – | ﹤0.01% | 2800 |
|
|
2023
Q2 | $88.7K | Buy |
+12,254
| New | +$88.7K | ﹤0.01% | 2746 |
|
|
2021
Q4 | – | Sell |
-7,721
| Closed | -$137K | – | 2506 |
|
|
2021
Q3 | $137K | Hold |
7,721
| – | – | ﹤0.01% | 2293 |
|
|
2021
Q2 | $147K | Buy |
+7,721
| New | +$147K | ﹤0.01% | 2334 |
|